NovaBridge Biosciences (NBP) › Capital ExpendituresNovaBridge Biosciences (NBP) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: 20.33M CNY2018: 14.41M CNY2019: 12.24M CNY2020: 8.01M CNY2021: 29.93M CNY2022: 45.83M CNY2023: 11.35M CNY11.35M CNY2017Capital Expenditures (CNY)2023Fiscal YearCapital ExpendituresChange YoY202311.35M CNY-75.2%202245.83M CNY+53.1%202129.93M CNY+273.8%20208.01M CNY-34.6%201912.24M CNY-15.0%201814.41M CNY-29.1%201720.33M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share